|
|
 |
ANHYDROUS LACTOSE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
OSPHENA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
OMNARIS Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ONPATTRO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
OXLUMO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLACRILIN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|